Navigation Links
Ferring Pharmaceuticals Provides Baby Quest Foundation Grant Recipients with Free Access to Fertility Medication

PARSIPPANY, N.J., Aug. 20, 2013 /PRNewswire-USNewswire/ -- In a continued effort to support patients facing infertility, Ferring Pharmaceuticals Inc. today announced a donation to Baby Quest Foundation, Inc. – a non-profit organization focused on providing financial assistance to patients pursuing fertility treatment. Through this collaboration, Ferring will provide 10 Baby Quest grant recipients with free access to select fertility medications, enabling them to undergo one full IVF cycle, with the hopes of helping them achieve their dream of parenthood.


It is estimated that about 6.7 million women between the ages of 15 to 44 in the U.S. experience infertility or the inability to carry a baby to term. [i]

"Each year, millions of families struggle with getting pregnant," said Justin Rauschkolb, Manager of Product Promotions of Ferring's reproductive health unit.  "Through our work with Baby Quest, we aspire to help some of these patients build and grow their families, while also providing hope for others still on the journey to becoming parents."

Ferring and Baby Quest kicked off their partnership at NASDAQ, where Baby Quest co-founder Pamela Hirsch and team rang the opening bell.  

"We are so thankful for the generosity of Ferring Pharmaceuticals in donating medication so that our grant recipients can pursue infertility treatment," said Hirsch.  "Their donation allows us to continue our work of increasing public awareness of the condition of infertility and of providing financial assistance to those who cannot afford the high costs of fertility treatments."

Ferring, as a company, has a commitment to helping patients realize their dream of parenthood. In addition to their work with Baby Quest, Ferring has other initiatives supporting both patients facing infertility and the community including:

  • Heart Beat Patient Assistance Program – Offers financial assistance for eligible patients pursuing fertility preservation services prior to cancer treatment. For more information, visit
  • 2013 Heart to Heart Video Contest – Allows participants the chance to win up to $15,000 toward their child's education for submitting a video essay telling the story of their steps on the path to parenthood. For more information or to submit a video by the August 31st deadline, visit
  • Local Playground Adoption – The Reproductive Health Unit of Ferring's Parsippany office adopted a local playground as a part of the Morristown "Adopt-a-Spot" program and Ferring's "Living the Philosophy" initiative, which grants employees one day per quarter to dedicate to service. Ferring will be responsible for upkeep of the park throughout the year. For more information about Ferring's community involvement, visit

To learn more about Ferring's initiatives in reproductive health, visit

About Ferring Pharmaceuticals Inc.

Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of reproductive health, urologygastroenterologyendocrinology and osteoarthritis. For more information, visit

[i]"Infertility." Centers for Disease Control and Prevention. 2013.

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals Inc. Announces $1M Donation to the Alliance for Fertility Preservation, a Newly Formed Charitable Organization
2. Ferring Pharmaceuticals Extends Its Heart to Heart Video Contest
3. Ferring Pharmaceuticals Inc. Adopts Local Morristown Playground
4. Ferring Announces It Will Present Phase 3 Data for Cervical Ripening Agent at American College of Obstetricians and Gynecologists Annual Clinical Meeting
5. Ferring to Highlight Phase 3 Data for Cervical Ripening Candidate at Society for Maternal-Fetal Medicine Annual Meeting
6. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
7. Ferring Pharmaceuticals Inc. Named 10th Fastest Growing New Jersey Company
8. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
9. Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
10. HedgePath Pharmaceuticals, Inc. Completes Reorganization Plan with Commonwealth Biotechnologies
11. TetraLogic Pharmaceuticals Announces New Executives
Post Your Comments:
(Date:9/22/2017)...  As the latest Obamacare repeal effort moves is ... (R-LA) and Lindsey Graham (R-SC) medical device ... industry is in an odd place.  The industry wants ... tax on medical device sales passed along with the ... increased visits and hospital customers with the funding to ...
(Date:9/19/2017)... Sept. 19, 2017   ZirMed Inc ., a recognized ... announced that it has been ranked #1 by its users ... Rankings 2017 User Survey. ZirMed was recognized as the ... hospitals and medical centers over 200 beds and holds one ... technology user survey history. ...
(Date:9/13/2017)... 13, 2017   OrthoAtlanta has been named the ... Host Committee (AFHC) for the 2018 College Football Playoff (CFP) ... at Mercedes-Benz Stadium in Atlanta, Georgia . ... "I,m In" campaign, participating in many activities leading up to, ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for care ... is the 90-day elimination period, when the family pays for care, is often waived, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
Breaking Medicine News(10 mins):